semaglutide after sleeve gastrectomy weight regain study versus placebo in individuals with poor loss bariatric surgery: a double-blinded, randomized, placebo-controlled trial Interest in Treatment with GLP-1

With the crisp strobe, the tilt function and the ability to flash with colours as well as to animate the pixel control, we have a great and versatile device at our disposal. We were also very enthusiastic about the expansion of the JDC family, the first device being the JDC Line, concluded Franken

Improved Insulin Sensitivity Emerging research suggests that GIP receptor activation may enhance insulin action in peripheral tissues, further improving glucose disposal

In a randomized trial of semaglutide 2.4 mg vs placebo for 1 year, 529 participants with HFpEF with a BMI of 30 kg/m2, there was a very large reduction in symptoms, improvement in exercise function in the GLP-1 drug assigned group

Endocrinol Diab Metab